Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer
Access status:
Open Access
Type
ArticleAuthor/s
Sjoquist, KMFriedlander, ML
O'Connell, RL
Voysey, M
King, MT
Stockler, MR
Oza, AM
Gillies, K
Martyn, JK
Butow, PN
Date
2013-01-01Publisher
AlphaMed PressLicence
The Oncologist® (pISSN 1083-7159) and The Oncologist Online (eISSN-1549-490X) and all contributions included therein are protected by copyright. All rights are reserved under United States and international copyright laws and other applicable laws and conventions. No copyright is claimed in any original work created by agencies or employees of the United States government. No part of this publication may be reproduced or transmitted in any form without the prior written consent of AlphaMed Press or Copyright Clearance Center http://copyright.com, e-mail: [email protected]. Certain provisions of the Copyright Act of 1976, as amended, respecting fair use and reproduction by libraries and archives, 17 U.S.C. §§ 107 and 108, may be applicable.Citation
Sjoquist KM, Friedlander ML, O'Connell RL, Voysey M, King MT, Stockler MR, Oza AM, Gillies K, Martyn JK, Butow PN. Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. Oncologist. 2013;18(11):1221-8.Share